BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)

Delayed Data
As of 4:00pm ET
 -0.69 / -5.92%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for BioCryst Pharmaceuticals Inc have a median target of 15.50, with a high estimate of 30.00 and a low estimate of 12.00. The median estimate represents a +42.40% increase from the last price of 10.89.

Analyst Recommendations

The current consensus among 12 polled investment analysts is to Buy stock in BioCryst Pharmaceuticals Inc. This rating has held steady since November, when it was upgraded from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Feb 28

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 28.85%
Growthannually -7.69%


Growthquarterly 1.55%
Growthannually 70.00%
Key to the earnings and sales forecast charts.